4D Molecular Therapeutics (FDMT)

• Market cap: $490M
• 1 day: -3.85%
• 5 days: -9.48%
• 1 month: 26.2%
• 3 months: 81.66%
• 6 months: 236.54%
• Year to date: 80.1%
• 1 year: 26.81%
• 5 years: -74.07%
• 10 years: -74.07%
• Sector: Healthcare
• Industry: Biotechnology

About: 4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Employees: 227